Correlation Between ARCA Biopharma and Arbutus Biopharma

Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and Arbutus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and Arbutus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ARCA Biopharma and Arbutus Biopharma Corp, you can compare the effects of market volatilities on ARCA Biopharma and Arbutus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of Arbutus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and Arbutus Biopharma.

Diversification Opportunities for ARCA Biopharma and Arbutus Biopharma

0.52

Correlation Coefficient

ARCA Biopharma  Arbutus Biopharma

Very weak diversification

The 3 months correlation between ARCA and Arbutus is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and Arbutus Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arbutus Biopharma Corp and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with Arbutus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arbutus Biopharma Corp has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and Arbutus Biopharma go up and down completely randomly.

Pair Corralation between ARCA Biopharma and Arbutus Biopharma

Given the investment horizon of 90 days ARCA Biopharma is expected to generate 1.42 times more return on investment than Arbutus Biopharma. However, ARCA Biopharma is 1.42 times more volatile than Arbutus Biopharma Corp. It trades about 0.04 of its potential returns per unit of risk. Arbutus Biopharma Corp is currently generating about 0.02 per unit of risk. If you would invest  228.00  in ARCA Biopharma on January 25, 2024 and sell it today you would earn a total of  137.00  from holding ARCA Biopharma or generate 60.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ARCA Biopharma  vs.  Arbutus Biopharma Corp

ARCA Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ARCA Biopharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, ARCA Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Arbutus Biopharma Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Arbutus Biopharma Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Arbutus Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ARCA Biopharma and Arbutus Biopharma

The main advantage of trading using opposite ARCA Biopharma and Arbutus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, Arbutus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arbutus Biopharma will offset losses from the drop in Arbutus Biopharma's long position.

The idea behind ARCA Biopharma and Arbutus Biopharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..